EDIT CIK: 1650664

Editas Medicine, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−193
FY22:
−226
FY23:
−169
FY24:
−251
FY25:
−160
(positive)
Change from FY21 to FY23
millions USD
FY21:
−188
FY22:
−220
FY23:
−163
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY23
millions USD
FY21:
−193
FY22:
−220
FY23:
−153
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−193
FY22:
−220
FY23:
−153
FY24:
−237
FY25:
−160

All amounts in millions USD Data sources:SEC EDGARTwelve Data